Allarity Therapeutics Inc (ALLR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,858 | -5,052 | -2,732 | -24,515 | -17,062 |
| Depreciation Amortization | -21 | 23 | 11 | 9,712 | 9,711 |
| Income taxes - deferred | N/A | N/A | N/A | -446 | -446 |
| Accounts payable and accrued liabilities | 433 | 436 | 177 | -4,108 | -3,623 |
| Other Working Capital | -4,385 | -3,569 | -149 | 63 | -3,843 |
| Other Operating Activity | 254 | -5 | 7 | 1,942 | 1,117 |
| Operating Cash Flow | $-11,577 | $-8,167 | $-2,686 | $-17,352 | $-14,146 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -298 | N/A |
| Investing Cash Flow | $N/A | $0 | $N/A | $-298 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 1,340 | 4,278 |
| Debt Repayment | N/A | N/A | N/A | -1,340 | -1,340 |
| Common Stock Issued | 13,594 | 11,143 | 11,143 | 37,354 | 33,119 |
| Common Stock Repurchased | -2,706 | -2,565 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | 0 | -562 | -3,500 |
| Financing Cash Flow | $10,888 | $8,578 | $11,143 | $36,792 | $32,557 |
| Exchange Rate Effect | -1,949 | -2,143 | -286 | 225 | -114 |
| Beginning Cash Position | 19,533 | 19,533 | 19,533 | 166 | 166 |
| End Cash Position | 16,895 | 17,801 | 27,704 | 19,533 | 18,463 |
| Net Cash Flow | $-2,638 | $-1,732 | $8,171 | $19,367 | $18,297 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,577 | -8,167 | -2,686 | -17,352 | -14,146 |
| Capital Expenditure | N/A | N/A | N/A | -298 | N/A |
| Free Cash Flow | -11,577 | -8,167 | -2,686 | -17,650 | -14,146 |